A retrospective study of use of atezolizumab in combination with bevacizumab, carboplatin and paclitaxel in no-small cell lung cancer patients
Latest Information Update: 25 Jul 2021
At a glance
- Drugs Atezolizumab (Primary) ; Bevacizumab; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 25 Jul 2021 New trial record
- 08 Jun 2021 Results presented at the 57th Annual Meeting of the American Society of Clinical Oncology